Toggle Offcanvas
...
 
Western Europe pharmaceuticals tenders

Western Europe pharmaceuticals tenders

Get access to latest Western Europe pharmaceutical tenders and bids. Find business opportunities and business intelligence for Western Europe pharmaceutical tenders, Western Europe pharmaceuticals bids contracts, pharma public procurement notices, Western Europe drugs tenders, Western Europe medicine tenders, Western Europe generic medicine tenders, pharmaceutical market reports, pharmaceutical market intelligence. Find Western Europe tenders, bids, procurement, RFPs, RFQs, ICBs. Search for Western Europe pharmaceutical tenders online.

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs. The global pharmaceuticals market produced treatments worth $1,228. 45 billion in 2020 and showed a compound annual growth rate (CAGR) of 1. 8%.

Western Europe is the western region of Europe. The region's countries and territories vary depending on context. Western Europe is one of the richest regions of the world. Germany has the highest gross domestic product in Europe and the largest financial surplus of any country, Luxembourg has the world's highest GDP per capita, and Germany has the highest net national wealth of any European state. Switzerland and Luxembourg have the highest average wage in the world, in nominal and PPP, respectively. Norway ranks highest in the world on the Social Progress Index. Countries in Western Europe - Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, Netherlands, and Switzerland

2854 Live Notices for Western Europe pharmaceuticals tenders

Showing 1 to 20

Substitute Health Insurance Generics No. 22
country Germany
posting date13 Aug 2024
deadline20 Sep 2024
Civil Engineering - New Building Impc (Pharmacy), Building 2441, Beethovenstraße, 38106 Bs
country Germany
posting date13 Aug 2024
deadline27 Aug 2024
Rapid Drug Tests
country Germany
posting date13 Aug 2024
deadline12 Sep 2024
Carrying Out Health Checks On Private Sector Employees Aged 40 And Over, Health Checks For Managers And Flu Vaccination Campaigns For Volunteer Employees.
country France
posting date13 Aug 2024
deadline16 Sep 2024
Federal City Of Bonn - Delivery Of Medical Consumables For The Emergency Services
country Germany
posting date13 Aug 2024
deadline24 Sep 2024
Drug Outpatient Clinics
country Germany
posting date13 Aug 2024
deadline09 Sep 2024
Medicines Containing The Active Ingredient Rasagiline (Atc: N04Bd02)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Ingredient Febuxostat (Atc: M04Aa03)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Ingredient Naproxen (Atc: M01Ae02)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Open House Discount Contracts 2024-10
country Germany
posting date13 Aug 2024
deadline30 Sep 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Pazopanib (L01Ex03) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Tobramycin (Atc Code: J01Gb01).
country Germany
posting date13 Aug 2024
deadline28 Jul 2026
Bvaeb Framework Agreement On Medicinal Products 2024
country Austria
posting date13 Aug 2024
deadline12 Sep 2024
Veterinary Clinical Information System
country Austria
posting date13 Aug 2024
deadline27 Aug 2024
Medicines Containing The Active Ingredient Dexamethasone (Atc: S01Ba01 - Without Implants)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Substance Sorafenib (Atc: L01Ex02)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Ingredient Telmisartan (Atc: C09Ca07)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Medicines Containing The Active Ingredient Combination Timolol And Latanoprost (Atc: S01Ed61)
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen (Atc Code: M01Ae02).
country Germany
posting date13 Aug 2024
deadline28 Jul 2026
Pharmaceutical Discount Agreements For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Aug 2024
deadline03 Aug 2026